Outcomes of Olverembatinib Based Regimen in Patients with Philadelphia Chromosome-Positive Advanced Leukemias: A Real-World, Single-Center Experience

Ziyu Wen(Nanfang Hospital), Na Xu(Changchun University), Qifa Liu(University of Science and Technology of China), Jing Sun(Qiqihar University), Xuan Zhou(Nanfang Hospital), Xiaoli Liu(Ningbo Kangning Hospital), Zhiping Fan(Nanfang Hospital)
Blood
November 15, 2022
Cited by 3


Related Papers